We could go back to having a life
Years after the pandemic reshaped daily life, millions remain caught in its shadow — not from the virus itself, but from what it leaves behind. Researchers at the University of Pennsylvania and Yale are now beginning to map the biological terrain of long COVID, identifying how lingering viral fragments and exhausted immune systems may sustain suffering long after infection clears. These findings do not yet offer a cure, but they offer something nearly as precious: a reason to believe that what has been broken might, in time, be understood — and perhaps repaired.
- Millions worldwide remain trapped in cycles of exhaustion, brain fog, and breathlessness months or years after their initial COVID infection, with no approved treatment and no clear biological explanation — until now.
- University of Pennsylvania researchers discovered that viral fragments persisting in the gut may trigger a chain reaction that depletes serotonin throughout the body, potentially explaining cognitive symptoms like memory loss and sleep disruption.
- Yale immunologists found that long COVID patients show exhausted immune cells and reactivated dormant viruses like Epstein-Barr, suggesting the immune system may be too worn down to suppress infections it once held quietly in check.
- Existing medications — SSRIs and tryptophan supplements — are emerging as potential treatment targets, though researchers caution these are early-stage hypotheses that require rigorous clinical validation before reaching patients.
- For people like Montreal physician Dr. Anne Bhéreur, who has spent years managing debilitating symptoms, these discoveries are not just scientific milestones — they are the first credible signal that a return to ordinary life may one day be possible.
For years, a haunting question has followed researchers studying long COVID: why do some people emerge from even a mild infection only to spend months or years trapped in exhaustion, confusion, and breathing difficulties? The condition has affected millions worldwide, yet its biological mechanisms remained largely mysterious. Now, two major studies are beginning to sketch out answers.
Researchers at the University of Pennsylvania, publishing in the journal Cell, found that some long COVID patients still harbor fragments of the virus in their gut long after testing negative. These remnants appear to trigger the body's viral alarm system, setting off an inflammatory response that damages the gut's ability to absorb tryptophan — the amino acid needed to produce serotonin. The result is a widespread serotonin depletion that may explain brain fog, memory problems, sleep disturbances, and digestive issues.
A parallel Yale study, published in Nature, examined blood samples from long COVID patients alongside recovered and never-infected individuals. Long COVID patients showed exhausted immune cells, abnormally low cortisol levels, and — strikingly — reactivated Epstein-Barr virus, a dormant pathogen most people carry silently. The findings suggest COVID may suppress the immune system enough to allow latent infections to resurface and sustain ongoing symptoms.
The two studies complement each other, pointing toward real biological pathways even as researchers caution that the work is preliminary and the samples small. A separate U.K. study adds further texture, finding that prolonged symptoms follow other respiratory infections too, hinting that post-infection syndromes may share common mechanisms across diseases long overlooked by medicine.
The practical implications are cautious but real. The serotonin findings suggest SSRIs and tryptophan supplementation as possible treatment avenues. Clearing viral reservoirs in the gut is another hypothesis under consideration. None of these have been tested clinically yet.
For Dr. Anne Bhéreur, a Montreal physician who has lived with long COVID since late 2020 — managing shortness of breath, nausea, fatigue, and the constant threat of relapse — the research represents more than academic progress. She knows the road from discovery to treatment can span decades. But the possibility of addressing the root cause, she says, would mean the chance to have a life again. For millions still waiting, that possibility matters deeply.
For years, the question has haunted researchers: Why do some people emerge from even a mild COVID infection only to find themselves trapped in months or years of exhaustion, confusion, and breathing troubles? The condition—formally called post-COVID-19 condition, or long COVID—has affected millions worldwide, yet its mechanisms remained largely mysterious. Now, several research teams are beginning to sketch out the biological pathways that might explain it, offering the first real hope that treatments could follow.
Two major studies published recently have identified potential biomarkers—measurable signals in blood, tissue, or bodily fluids that can point to disease—that distinguish long COVID patients from those who recovered fully. The first, from researchers at the University of Pennsylvania including microbiologist Christoph Thaiss, appeared in the journal Cell and examined both real patients and animal models. What they found was striking: some people with long COVID still harbored fragments of the virus in their gut long after they stopped testing positive. These lingering particles appear to trigger the release of interferons, proteins that act as the body's viral alarm system. That alarm, in turn, sets off a chain reaction. The inflammatory response damages the gut's ability to absorb tryptophan, an amino acid essential for making serotonin. The result is a peculiar depletion: serotonin levels drop everywhere in the body except the brain, disrupting the nervous system in ways that can produce memory problems, brain fog, sleep disturbances, and digestive issues.
A parallel study from Yale immunologist Akiko Iwasaki, published in Nature, examined blood samples from three groups: long COVID patients, people who recovered from COVID, and those never infected. The differences were clear. Long COVID patients showed exhausted immune cells and abnormally low levels of cortisol, a hormone that regulates metabolism and immune function. More intriguingly, Iwasaki's team found that dormant Epstein-Barr virus—a common pathogen that infects most people at some point—had reactivated in long COVID patients. This suggests that COVID infection may have dampened the immune system enough to allow latent viruses to wake up and potentially contribute to ongoing symptoms.
These findings are preliminary, and researchers emphasize they're still in early stages. The studies are relatively small and focused on specific mechanisms. Yet they complement each other in ways that suggest real biological pathways are at work. William Schaffner, an infectious diseases specialist at Vanderbilt University who was not involved in either study, notes that the central mystery remains: Why can't some people turn off their inflammatory response? Why does it continue to smolder, causing damage long after the initial infection has cleared?
The research also reveals that long COVID may not be unique. A recent U.K. study analyzing data from over 10,000 adults found that lingering health problems follow other respiratory infections too—influenza, the common cold. Some symptoms overlap with long COVID; others are distinct. This suggests that post-infection syndromes may share common biological mechanisms, a finding that could eventually help scientists understand and treat a whole category of conditions that have been largely ignored.
The practical implications are beginning to emerge. The serotonin findings point toward existing medications—SSRIs, the class of antidepressants most commonly prescribed—as potential treatment targets. Tryptophan supplementation or drugs that eradicate the viral reservoir in the gut might also help. But these are hypotheses awaiting testing.
For those living with long COVID, the research represents something more than academic progress. Dr. Anne Bhéreur, a Montreal physician who contracted COVID in late 2020, has spent years managing shortness of breath, difficulty speaking, nausea, dizziness, and crushing fatigue. Various treatments have helped, but there is no cure. Even now, overexertion can trigger a relapse. She knows that the path from research discovery to clinical treatment can take decades—one study suggests an average of 17 years. Yet she holds onto hope. "Knowing that they could treat the root cause, that we could reverse what's going on, would also mean we could go back to having a life," she said. For millions still trapped in the aftermath of infection, that possibility—however distant—matters.
Notable Quotes
We're getting the sense that there are some tangible mechanisms that can produce some of these symptoms, and many of them might actually be, surprisingly, shared among many of these conditions.— Christoph Thaiss, University of Pennsylvania microbiologist
Knowing that they could treat the root cause, that we could reverse what's going on, would also mean we could go back to having a life.— Dr. Anne Bhéreur, Montreal physician with long COVID
The Hearth Conversation Another angle on the story
So these researchers found virus fragments still hiding in people's guts. How is that possible if they've tested negative?
The virus itself may be gone, but pieces of it remain. Think of it like debris after a fire—the flames are out, but the ash is still causing problems. Those fragments keep triggering the body's alarm system.
And that alarm system—the interferons—that's what depletes the serotonin?
Exactly. The alarm causes inflammation in the gut, which damages the lining's ability to absorb tryptophan, the raw material the body needs to make serotonin. So you end up with a shortage everywhere except the brain.
That's oddly specific. How did they figure that out?
They looked at blood samples and stool samples from long COVID patients and compared them to people who recovered normally. The pattern emerged when they traced the chain of events.
The Yale study found reactivated dormant viruses. That's a different mechanism entirely, isn't it?
It is, but it points to the same problem: a weakened immune response. COVID seems to exhaust the immune system enough that old infections wake up. Both studies suggest the body's defenses are compromised in specific ways.
So we're looking at multiple mechanisms, not one cause?
That's the working theory now. Different people may develop long COVID through different pathways. Some might have the serotonin problem, others the reactivated viruses, maybe some have both.
And the SSRIs—antidepressants—might help because they preserve serotonin?
That's the hypothesis. But it's still just a hypothesis. They need to test whether raising serotonin levels actually reverses the symptoms people are experiencing.